Shares of Amplitude surged 8.5% to $8.30 after Raymond James analyst Mark Cash launched coverage with a Strong Buy rating and a $10 price target, capping a ferocious week-long rally from the mid-$6 range. The target implies roughly 30% upside from the prior close of $7.65 , and the initiation adds Wall Street firepower to a stock that had been punished — down 35% over six months as AI-driven valuation compression and company-specific execution concerns hammered the price .
A Fresh Bull Thesis Rests on Accelerating Growth
Cash cited favorable risk/reward as Amplitude's growth accelerates.
Raymond James pointed to improving organic growth, retention, and expansion with stronger forward visibility. The numbers back that up: Q1 2026 revenue hit $93.5 million, up 17% year-over-year, while annual recurring revenue — the subscription income the company expects over the next 12 months — reached $374 million, also up 17%.
Dollar-based net expansion, a measure of how much existing customers increase their spending, improved to 106% , a sign that clients are buying more, not leaving.
The Cash-Flow Problem Hasn't Gone Away Growth is real, but profitability remains elusive. Gross margin slipped to 75% from 77% as higher AI computing costs ate into revenue, and free cash flow worsened to negative $13.2 million from negative $9.2 million a year earlier.
For the full year, management is guiding for just $2.5 to $6.5 million in non-GAAP operating income — paper-thin, and heavily dependent on the company controlling its AI investment bill.
AI Is the Opportunity and the Risk
Raymond James believes downside is limited if Amplitude's behavioral data and action-oriented analytics platform remain relevant in the emerging era of AI-powered software agents. The company is betting heavily on this, integrating its recent Statsig acquisition and launching new AI products, even as short-term gross margin pressure is expected to persist. That's a classic trade-off: invest now, prove returns later.
Wall Street Is Mostly on Board — For Now
Nine analysts recommend buying and none say sell; the average 12-month target sits at $10.59, ranging from $7 to $18.
Management raised full-year 2026 revenue guidance to $397–$403 million , implying mid-teens growth all year. The question is whether Amplitude can convert that top-line momentum into real profits before investor patience — and a $1 billion market cap — runs thin.